SK Life Science - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsSK Life Science

SK Life Science

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Xcopri	Cenobamate	2020-03-10	2032-2039	Epilepsy , Partial epilepsies

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

nervous system diseases

,

,

,

hepatic insufficiency

,

partial epilepsies

,

generalized epilepsy

,

,

,

partial epilepsy motor

,

,

,

myeloid leukemia acute

,

myeloid leukemia

,

deficiency diseases

,

paraproteinemias

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

lymphoid leukemia

,

breast neoplasms

,

immune system diseases

,

hematologic neoplasms

,

type 2 diabetes mellitus

,

,

metabolic diseases

,

,

,

immunoglobulin g4-related disease

,

,

falciparum malaria

,

,

,

,

,

polycystic kidney diseases

,

autosomal dominant polycystic kidney

,

,

renal insufficiency

,

hematologic diseases

,

blood protein disorders

,

neoplasms by histologic type

,

prostatic neoplasms

,

circulating neoplastic cells

,

heart transplantation

,

non-small-cell lung carcinoma

,

,

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

esophageal neoplasms

,

,

neoplasm metastasis

,

,

aplastic anemia

,

multiple myeloma

,

plasma cell neoplasms

,

hypercholesterolemia

,

hyperlipoproteinemia type ii

,

meningococcal infections

,

hemolytic anemia autoimmune

,

,

meningococcal meningitis

,

stomach neoplasms

,

,

kidney diseases

,

gaucher disease

,

smoldering multiple myeloma

,

,

chronic renal insufficiency

,

hyperphosphatemia

,

multiple sclerosis

,

,

homozygous familial hypercholesterolemia

,

,

,

healthy volunteers/patients

,

,

glycogen storage disease type ii

,

glycogen storage disease

,

atopic dermatitis

,

,

,

,

diabetes mellitus

,

,

glycogen storage disease type iii

,

non-hodgkin lymphoma

,

,

postmenopausal osteoporosis

,

lymphoproliferative disorders

diabetic neuropathies

,

peripheral nervous system diseases

,

,

postherpetic neuralgia

,

,

irritable bowel syndrome

,

healthy volunteers/patients

therapeutic equivalency

,

pharmacokinetics

,

,

communicable diseases

,

,

alzheimer disease

,

,

juvenile arthritis

,

,

,

chronic pancreatitis

,

exercise-induced asthma

,

breast neoplasms

,

hematologic neoplasms

,

,

,

,

gastrointestinal diseases

,

,

,

,

peptic ulcer hemorrhage

,

rheumatoid arthritis

,

,

,

gastrointestinal hemorrhage

,

digestive system diseases

,

digestive signs and symptoms

,

simian acquired immunodeficiency syndrome

,

eosinophilic esophagitis

,

esophageal neoplasms

,

precancerous conditions

,

,

,

,

zollinger-ellison syndrome

,

,

postpartum hemorrhage

,

gastroesophageal reflux

,

peptic esophagitis

,

healthy volunteers/patients

,

,

,

,

,

barrett esophagus

,

non-erosive reflux disease

,

laryngopharyngeal reflux

,

,

,

,

,

atrophic gastritis

,

,

,

,

bariatric surgery

,

critical illness

,

,

,

pathologic constriction

,

,

,

microscopic colitis

,

,

metabolic diseases

,

calcium metabolism disorders

,

,

,

vasomotor rhinitis

,

colorectal neoplasms

,

,

healthy volunteers/patients

,

chronic obstructive pulmonary disease

,

,

coronary artery disease

,

non-small-cell lung carcinoma

,

,

,

squamous cell carcinoma

,

squamous cell neoplasms

,

rheumatoid arthritis

,

,

hypercholesterolemia

,

breast neoplasms

,

triple negative breast neoplasms

peripheral nervous system diseases

,

diabetic neuropathies

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use